Molecular You is thrilled to partner with HealthQuest Esoterics, a leader in laboratory testing, to expand access to molecular medicine across the U.S.!🎉 Together, we’re on a mission to transform preventive care, address health issues at the root cause, and improve health outcomes for healthcare providers and their patients. 🧬💡 "Partnering with HealthQuest Esoterics is a key step in our mission to expand access to molecular medicine," said Jim Kean, CEO of Molecular You. "We're excited to see our molecular testing and analytics solutions implemented across the U.S., helping practitioners to better understand their patients' health through detailed biomarker insights, and take action even before symptoms appear." Read about the partnership on this link: https://bit.ly/3O4yY8Y #MolecularYou #HealthQuestEsoterics #PreventiveCare #PredictiveMedicine #HealthcareInnovation #BiomarkerInsights
Molecular You’s Post
More Relevant Posts
-
Imagine a future where every treatment is crafted for you—not just based on your condition, but on the unique story written in your DNA. 🌌💫 On this journey toward truly personalized care, the PREPARE Study has opened doors we once only dreamed of. Join us for an IVPN webinar, “The PREPARE Study: Results and Future Perspectives,” led by world-renowned experts: Professor Jesse Swen and Professor Nancy Hakooz . Together, we’ll explore the revolutionary science of pharmacogenomics (PGx), where treatments are crafted specifically for you, reducing risks and unlocking better outcomes. This is more than progress; it’s a promise—a future where healthcare is as individual as the lives it touches. Step into this new era with us, where you are seen, valued, and at the heart of every choice. secure your spot now! Date: October 31, 2024 Time: 5:00 PM (KSA Time) Platform: Zoom IVPN-Network, FZ, LLE , IVPN - Personalized Medicine #PREPAREStudy #PersonalizedCare #Pharmacogenomics #IVPN #FutureOfHealthcare
To view or add a comment, sign in
-
Advancing Care through Cost-Effective Molecular Testing 3EO Health is dedicated to #BreakingDownFinancialBarriers to molecular testing with our cost-effective high efficiency 3TR tests. By reducing the costs associated with molecular testing, we're opening doors to high-quality care for more patients. Why #CostEfficiencyMatters : ✨ Expanding Access: Lower test costs help healthcare providers offer molecular testing to a broader patient base, essential for early intervention and personalized care plans. ✨ Sustaining Healthcare: By making molecular tests more affordable, we contribute to the financial health of healthcare institutions, ensuring resources are allocated efficiently. ✨ Alleviating Patient Burden: Our affordable testing options reduce the economic impact on patients. We believe that cost should not be the factor that prevents access to molecular testing. We are here to deliver cost-effective, quality molecular testing solutions for EveryOne. Learn more at 3EOhealth.com #MakingMolecularMatter #AccessibilityForAll #AffordabilityNotCompromise
To view or add a comment, sign in
-
In private market investing, healthcare hasn't historically been the most enticing industry for individual investors. After all, compared to some other industries, healthcare has long proof-of-market-viability time horizons and has lagged in embracing digitization and technological advancements. However, a notable shift is underway. Enter health tech, bio tech, precision medicine and diagnostics tech. This burgeoning world of life science advancements has awakened investors' interest with its financial and healthcare potential. Two personal favorites in this arena are genomic health and CRISPR (clustered regularly interspaced short palindromic repeats) technology. https://lnkd.in/g_nt4wAy #healthcare #healthcareinnovations #healthcaretechnology #technology #innovation #healthcaresystems #hospitals #physicians #healthcareproviders #healthcareprofessionals #healthcareaccess #patientcentric #patientcare #genomic #genomichealth #medicine
To view or add a comment, sign in
-
RT @MDPIOpenAccess Exploring Diet-Based Treatments for Atrial Fibrillation: Patient Empowerment and Citizen Science as a Model for Quality-of-Life-Centered Solutions https://buff.ly/4dGL17c @amomx3
To view or add a comment, sign in
-
In today's rapidly evolving healthcare landscape, Patient-Centered Precision Medicine (PCPM) is revolutionizing how we approach treatment by integrating a multi-omics strategy. This innovative approach tailors medical care to the unique genetic, environmental, and lifestyle factors of each patient, ensuring that treatments are not just effective but also personalized. The significance of PCPM lies in its ability to utilize comprehensive biological data—from genomics to metabolomics—to inform clinical decisions. By understanding the intricate molecular profiles of patients, healthcare providers can predict responses to therapies more accurately, leading to improved outcomes and minimized side effects. This is especially crucial for managing complex diseases like cancer, where individual variations can significantly affect treatment efficacy. As we strive towards a more inclusive healthcare system, embracing PCPM with a multi-omics perspective not only enhances patient care but also aligns with global health goals for equitable access to innovative treatments. Let’s champion this transformative approach that puts patients at the heart of their healthcare journey! #PrecisionMedicine #PatientCenteredCare #MultiOmics #HealthcareInnovation #PersonalizedMedicine #HealthEquity #DataDrivenHealthcare Share Rewrite
To view or add a comment, sign in
-
Personalised medicine is about finding the right dose of the right medicine for each individual patient. It is the opposite approach to one size fits all. Checkout our latest blog to learn more about personalised medicine and how it is transforming healthcare, linked below. https://lnkd.in/eYFC27fm #PersonalisedMedicine #Healthcare
Genomics 101: What is personalised medicine?
genomicsengland.co.uk
To view or add a comment, sign in
-
🚨 Webinar Announcement: Improving Outcomes and Access to Precision Medicine🚨- https://lnkd.in/eSvkPZPG Despite groundbreaking advances in precision medicine, a critical gap remains: the lack of diverse representation in genomic data, leading to unequal healthcare outcomes—especially for people of color. 🔬 What is the impact? Genomic testing is a cornerstone of modern medicine, yet current databases are largely based on data from individuals of European descent. This leaves underrepresented populations at a disadvantage, with less effective treatments and limited access to life-saving innovations. 💡What you’ll learn: 1️⃣ Understanding the genomic testing gap and the structural barriers in healthcare 2️⃣ How to advance precision medicine for all, ensuring inclusivity 3️⃣ Practical strategies for improving access, including policy changes, community engagement, and innovative healthcare models 📅 Date: Thursday, 21st November, 2024 ⏰ Time: 12:00pm - 1:00pm ET 📍 Location: Zoom (Register Here https://lnkd.in/eSvkPZPG) Let’s work together to create a healthcare system that serves everyone. #PrecisionMedicine #GenomicTesting #HealthEquity
To view or add a comment, sign in
-
Grateful to have contributed to this article, now published! The piece discusses the value of Point Of Care (POC) ultrasound and X-ray technologies in extending diagnostic capabilities, particularly where radiologists are not readily accessible. These tools are helping to shift tasks and improve healthcare efficiency in low- and middle-income settings, as demonstrated by their use in tuberculosis programs, where detection rates have shown positive trends. Achieving Universal Health Coverage (UHC) by 2030 will depend on expanding such solutions, though important challenges remain. Training healthcare workers, developing locally relevant algorithms, and addressing ethical and regulatory needs are all essential steps. We conclude by underscoring the potential of POC diagnostics to support fair and resilient healthcare delivery globally. Scaling AI-supported POC technologies can be pivotal in making quality diagnostics more accessible, helping us move closer to UHC and a healthier world for all. Qure.ai Madhukar Pai, MD, PhD Prashant Warier FIND Divya Gupta Justy Antony Chiramal Nimmy Dominic Dr. Pragnesh Pokar Dara Kelleher Suridhi Sharma Ronika Susan George Sanya Chawla UHC2030 - Taking action for universal health coverage https://lnkd.in/g6ijhXJ7
The value of diagnostic imaging for enhancing primary care in low- and middle-income countries
sciencedirect.com
To view or add a comment, sign in
-
Why Finding Effective Biomarkers is a Must Join Dr. Bryan as he delves into the crucial role of impactful biomarkers in the medical industry. Discover why finding effective biomarkers is essential for improving patient care and the challenges posed by the healthcare system. Learn how change can reshape the future of medicine! #Biomarkers #MedicalInnovation #HealthcareChallenges #PatientCare #MedicalScience #HealthEducation #ClinicalPractice #FutureOfMedicine #MedicalIndustry #HealthAwareness
To view or add a comment, sign in
-
Ever felt like traditional medical approaches just don't quite fit your needs? You're not alone. Just finished reading the latest Nature article on this, which dives deeper into cutting-edge clinical trial designs like basket, umbrella, and platform trials. If you are curious about how these trials are reshaping the medical landscape, offering tailored solutions based on your unique biomarkers, this can be a good read. The link is in the comments section. Together, let's envision a future where healthcare is truly personalized just for you. 🚀 #PrecisionMedicine #YourHealthYourWay #FutureOfHealthcare American Association for Precision Medicine (AAPM) #aspmhealth #aapm_health #news
To view or add a comment, sign in
1,813 followers